U.S. market Closed. Opens in 11 hours 45 minutes

ORGO | Organogenesis Holdings Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue433.14M450.89M468.06M338.30M260.98M193.45MN/AN/A
Cost of Revenue123.35M105.02M114.20M87.32M75.95M68.81M4.59M208.70K
Gross Profit309.79M345.87M353.86M250.98M185.03M124.64M-4.59M-208.70K
Operating Expenses293.47M323.57M280.94M223.56M214.49M172.70MN/A208.70K
Selling, General & Admin242.51M283.81M250.20M203.48M199.69M161.96MN/AN/A
Research & Development44.38M39.76M30.74M20.09M14.80M10.74MN/AN/A
Other Operating Expenses-6.58M-13.00K-13.00K97.00K13.00K162.00KN/A208.70K
Operating Income16.32M22.30M72.92M27.41M-29.46M-51.56M-4.59M-208.70K
Other Expenses / Income-5.93M-2.02M-9.13M-8.94M-10.85M-5.90M2.50MN/A
Before Tax Income10.39M20.28M63.79M18.48M-40.30M-64.75M-2.09M-208.70K
Income Tax Expenses5.45M4.75M-31.12M530.00K150.00K84.00KN/AN/A
Net Income4.95M15.53M94.20M17.23M-40.45M-64.83M-2.09M-208.70K
Interest Expenses2.19M2.01M7.24M11.28M9.00M10.85M2.50MN/A
Basic Shares Outstanding131.23M130.07M128.33M107.74M92.84M69.32M9.33M7.92M
Diluted Shares Outstanding132.75M132.38M133.66M111.36M92.84M69.32M9.33M7.92M
EBITDA39.77M40.32M89.58M34.98M-20.02M-40.86M404.01K-208.70K
EBITDA Margin9.18%8.94%19.14%10.34%-7.67%-21.12%0.00%0.00%
EBIT12.58M22.29M70.32M29.04M-31.31M-53.89M404.01K-208.70K
EBIT Margin2.90%4.94%15.02%8.59%-12.00%-27.86%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙